1dok
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='1dok' size='340' side='right'caption='[[1dok]], [[Resolution|resolution]] 1.85Å' scene=''> | <StructureSection load='1dok' size='340' side='right'caption='[[1dok]], [[Resolution|resolution]] 1.85Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[1dok]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[1dok]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DOK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1DOK FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1dok FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1dok OCA], [https://pdbe.org/1dok PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1dok RCSB], [https://www.ebi.ac.uk/pdbsum/1dok PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1dok ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [[ | + | [[https://www.uniprot.org/uniprot/CCL2_HUMAN CCL2_HUMAN]] Chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. Augments monocyte anti-tumor activity. Has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis. |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Line 31: | Line 31: | ||
==See Also== | ==See Also== | ||
*[[Monocyte chemoattractant protein|Monocyte chemoattractant protein]] | *[[Monocyte chemoattractant protein|Monocyte chemoattractant protein]] | ||
- | *[[User:Coline Perrin/CCL2|User:Coline Perrin/CCL2]] | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 09:29, 21 July 2021
MONOCYTE CHEMOATTRACTANT PROTEIN 1, P-FORM
|